Table 1 Baseline clinical and echocardiographic characteristics
Total study population (n = 36) | Recurrent group (n = 21) | AF-free group (n = 15) | Normal values from the literature | Reference number | |
|---|---|---|---|---|---|
Clinical characteristics | |||||
Age (yrs) | 57.4 ± 8.9 | 59.6 ± 5.8 | 54.2 ± 11.5 | - | - |
Duration of AF(yrs) | 6.7 ± 7.3 | 8.8 ± 8.7 | 3.8 ± 3.3* | - | - |
Male (%) | 26 (72%) | 13 (62%) | 13 (87%) | - | - |
Hypertension (%) | 27 (75%) | 15 (71%) | 12 (80%) | - | - |
Obesity (%) | 10 (28%) | 3 (14%) | 7 (47%) | - | - |
Ischaemic HD | 4 (11%) | 3 (14%) | 1 (7%) | - | - |
Echocardiographic characteristics | |||||
LV EF (%) | 63 ± 5 | 64 ± 5 | 62 ± 6 | ≥ 55% | [19] |
LAV max (ml) | 71 ± 21 | 73 ± 23 | 67 ± 20 | < 56 | [19] |
LAVI (ml/m 2 ) | 34 ± 10 | 35 ± 10 | 33 ± 9 | < 29 | [19] |
LAV min (ml) | 36 ± 17 | 38+19 | 30 ± 12 | 25 ± 13 | [24] |
LA SI diam (mm) | 55 ± 5 | 55 ± 5 | 54 ± 6 | - | - |
LAEF (%) | 51 ± 10 | 48 ± 11 | 55 ± 8* | 56 ± 8 | [24] |
LAFF (%) | 35 ± 7 | 36 ± 7 | 34 ± 7 | 41 ± 14 | [24] |
PVSF (%) | 59 ± 8 | 58 ± 9 | 60 ± 7 | 60 ± 9 | [25] |
Aa lat (cm/s) | 10.1 ± 2.3 | 9.7 ± 2 | 10.7 ± 2.7 | - | - |
Aa sept (cm/s) | 9.1 ± 2 | 8.8 ± 1.8 | 9.7 ± 2.1 | - | - |
Ea lat (cm/s) | 11.1 ± 2.8 | 11.2 ± 2.4 | 10.9 ± 3.2 | > 10 | [23] |
Ea sept (cm/s) | 8.4 ± 2.3 | 8.1 ± 1.9 | 8.8 ± 2.8 | > 8 | [23] |
E/Ea avg | 7.3 ± 2 | 7.2 ± 1.8 | 7.3 ± 2.1 | < 8 | [23] |